SEPN ▼ -0.2% - Septerna, Inc.
$SEPN - Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting
04-NOV-2026 08:00 AM ET
Share this post
More filings for $SEPN
SEPN ▼ -0.6% - Septerna, Inc.Sep 10, 2026SEPN - Septerna, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026SEPN - Septerna, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $SEPN filing history →💬 Comments
Loading comments…
Leave a comment